Upcoming Speakers

Gamete selection in ART, trends and future prospects

Tuesday 23rd April , 16:00 – 16:45

With over 15 years of experience in the field of reproductive medicine, Dr Fab Horta is a medical reproductive scientist who combines clinical and academic expertise in the IVF field. He currently conducts research on infertility, biomarkers and non-invasive methods of gamete and embryo quality, artificial intelligence, reproductive genetics, and technology innovation in assisted reproductive technologies at the Fertility & Research Centre, UNSW and  he is a Scientific Supervisor of R&D at City Fertility, Australia.

Dr Horta is passionate about advancing the field of reproductive medicine and improving the outcomes and experiences of patients and clinicians. His vision is to create a world where infertility is no longer a barrier to start a family.

Mapping ethical, legal & social implications of assisted technologies

Tuesday 18th June , 16:00 – 16:45

Ido Alon, Ph.D., is a postdoctoral researcher at the Autonomous University of Madrid and the University of Montreal. He has recently published two articles that map and review twenty years of research on the ELSI of ART, supplementing his four earlier papers from his Ph.D. project that focused on the technological forecasting and regulatory assessment of ART in Israel and Spain.

Blastocyst derived lactate: more than just a metabolic waste product

Tuesday 22nd October, 16:00 – 16:45

Dr Kathryn Gurner is a Clinical Research Scientist at Melbourne IVF, Australia. Kathryn has over 5 years experience in basic science research in both embryology based work and endometrial biology and completed her PhD under the supervision of Professor David Gardner at the University of Melbourne. Her demonstrated research history has been focused on utilising animal and cell models to increase understanding of both sides of the maternal-fetal dialogue underpinning embryonic development and implantation.

AI: the next big thing, or a glorified algorithm

Tuesday 19th November, 16:00 – 16:45

Han Weerdesteyn graduated with a Biology MSc from the University of Nijmegen in 2001. He started his career with XiltriX designing and providing monitoring and alarm solutions for critical laboratory environments. He is currently commercial Director and co-owner of XiltriX International.

XiltriX has been used globally in the field of IVF/ART for more than 20 years for critical parameter monitoring and data analysis. His experience in this field gives him a unique insight in the new developments in AI and machine learning.